To find out the relevance of serum magnesium levels on the outcome of patients admitted in ICU.

Correlation of serum magnesium levels with clinical outcome in critically ill patients admitted to ICU

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Observational

Source

CTRI

Registry ID

CTRI/2019/02/017826

Enrollment

280

Registered

2019-02-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Critically ill patients admitted to ICU AGE LIMIT: 18 years and above

Exclusion criteria

Exclusion criteria: Patients with documented hypomagnesemia / hypermagnesemia before admission to ICU -Patients with previous magnesium supplementation -Mortality within 24 hours of admission to ICU -Critically ill patients in ICU in whom day 1 of serum magnesium testing is missed .

Design outcomes

Primary

Measure	Time frame
To study the incidence of hypomagnesemia and hypermagnesemia and to correlate serum magnesium levels at admission with mortality in critically ill patients in the ICU .Timepoint: 18 months	—

Secondary

Measure	Time frame
To correlate serum magnesium levels with length of ICU stay, need and duration of mechanical ventilation, other electrolyte abnormalities and biochemical parameters and co-morbid conditions in critically ill patients .Timepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Vandana Talwar

Guru Gobind Singh Indraprastha University

drvandanatalwar@gmail.com9811352251

Outcome results